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Summary
The Mexican axolotl (Ambystoma mexicanum) is one of the 
most widely used laboratory animals for research. It is able 
to regenerate multiple structures including the limbs, jaws, 
tail, spinal cord and skin among other organs. The mecha-
nisms governing regeneration, wound healing, development, 
and cancer formation are closely linked. There is increas-
ing evidence highlighting the common signalling pathways 
which link to cancer growth and regeneration whereby dys-
regulation of the well-balanced and coordinated process of 
regeneration leads to cancer. This review aims to highlight 
the regenerative capacity of axolotls and identify how the 
active molecules from regeneration extracts could lead to 
major benefits, with directions on how to develop therapeutic 
approaches for cancer treatment in humans.
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Introduction
 Salamanders are one of the oldest laboratory 
animal models used for research experiments. In 
1768, Lazzaro Spallanzani first described limb re-
generation in salamanders [1,2]. One of the earliest 
regenerative animals that made it to Europe all 
the way from Mexico is the Ambystoma mexicanum, 
more commonly known as the axolotl. It belongs 
to the class Amphibia family: Ambystomatidae. De-
scribed as larva, they were later classified as adults 
when it was observed they were able to reproduce. 
The axolotl became a very important model in the 
field of embryology and developmental biology 
[3], as well as research on thyroxine. Nowadays, 
the axolotl plays an important role in investigat-
ing and understanding stem cell biology [4], cancer 
[5], scarless wound healing, and aging [6]. 
What makes axolotls ideal models for research in can-
cer treatment?
 Several types of organisms such as hydra, pla-
narians, echinoderms, annelids, and amphibians 
can completely regenerate several tissues, organs 
or even whole body parts. Regeneration is usu-
ally classified as morphallaxis or epimorphosis. In 
morphallactic regeneration, such as in hydra, the 
remaining part of the amputated organism is re-
modelled to regenerate all parts of the body. In con-
trast, epimorphic regeneration, as seen in urodele 
amphibians, involves the regeneration of various 
tissues and complex structures. The axolotl and the 
newt (Notophtalmus viridescence) are the two most 
commonly used urodele amphibians in the labora-
tory and they are capable of regenerating different 
organs. The fact that they are able to regenerate 
complex structures makes the urodele amphibians 
important animal models not only in studying and 
understanding how regeneration occurs but also in 
the study of cancer. 
 The axolotl is one of the few tetrapods which 
are capable of regenerating complex biological 
structures such as limbs, tail, heart, eye lens, and 
central nervous system including the brain and 
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spinal cord [7]. Earlier research on the effect of 
carcinogens on axolotls has shown that they are 
resistant to tumour formation upon exposure to 
carcinogens [8]. In other experiments, tumor cells 
showed regression or they were incorporated into 
the normal tissues of the organism [8].
 The axolotl limb regeneration model is 
amongst the most studied regeneration models 
and the fact that many genes and signalling path-
ways are conserved between humans and axolotls 
makes this organism an ideal model in therapeutic 
research. In fact, even though the axolotl genome is 
10 times larger than the human genome at 32 gi-
gabases (GB), it roughly encodes a similar number 
of proteins as humans [1] with extensive conserva-
tion of synteny (blocks of order within two sets of 
chromosomes that are being compared with each 
other) between Ambystoma, chicken, and human, 
and a positive correlation between the length of 
conserved segments and genome size [9]. Several 
other reasons make the axolotls very attractive 
models for research, including their high reproduc-
tive rate and low maintenance requirements in the 
laboratory. In comparison to the newt (Notophtal-
mus viridescence), axolotls are much easier to breed. 
The fact that axolotls are sexually mature and yet 
maintain a larval state could prove to be pivotal to 
cancer research. 
Regeneration and Cancer
 Regeneration is a homeostatic process of re-
newal that involves a well-balanced and coordi-
nated process of restoration of cells, tissues, and 
organs that have been damaged or lost, resulting 
in total recovery of the structural and functional 
integrity of the part involved. It is characterised 
by tightly controlled and orderly overlapping pro-
cesses of inflammation, tissue reconstruction, and 
remodelling [10]. The process of regeneration must 
also integrate the newly-formed tissues with the 
pre-existing tissues. Moreover, regeneration must 
be able to have an orderly control to initiate and 
maintain signals, with the capacity to regulate the 
cell cycle, resulting in a finite number of cells that 
undergo division. Once the regeneration is com-
plete, the process must be terminated. A failure 
to switch off the signals that govern proliferation 
would lead to abnormal tissue repair, fibrosis, and 
uncontrolled cell growth or cancer [11]. 
 In humans, the ability to replace cells within 
a specific tissue is limited. With a few exceptions 
such as the finger tips, involving the distal/termi-
nal phalanges, and the liver, humans are unable to 
regenerate more complex structures that integrate 
the structure and function of multiple tissues [12]. 
Even though humans, to some extent, can repair 
tissues such as bone, peripheral nerves, and skin 
cells following ultraviolet exposure, these mecha-
nisms are not as efficient and error-free as the re-
generative abilities of certain animals. It is impor-
tant to note that even though these organisms are 
far superior in their regenerative capacities when 
compared to humans, the signalling pathways that 
govern regeneration, embryonic development, 
wound healing, and cancer are highly conserved 
in both humans and organisms with regenerative 
capabilities [13]. In fact, epithelial-mesenchymal 
transition (EMT), which is central for embryonic 
development, is also important during wound heal-
ing and regeneration and if unregulated, can lead 
to cancer. The signalling pathways (Notch, hedgehog 
(HH), Wnt, RTK, and TGFß) that regulate EMT are 
common among regeneration, embryonic develop-
ment, wound healing, and cancer. 
 In 1935, Waddington postulated the existence 
of ‘individuation fields’, agents which control the 
growth of different parts of an organism in a har-
monious way so that a normal individual is formed 
[14]. Cancers may form following an escape of can-
cer cells from the controlling influence of an indi-
viduation field and these cells might be brought 
under control again if they were exposed to the in-
fluence of a particularly strong individuation field, 
e.g. the regeneration field of a regenerating urodele 
limb [15]. This theory might be supported by the 
observation that spontaneous tumours are rarely 
observed in animals which are capable of regenera-
tion. However, it cannot be true for all regenerating 
organisms since the reactions of planaria and axo-
lotls to carcinogen exposure are different. Whereas 
axolotls resisted to cancer formation, exposure of 
planaria to carcinogens induced tumour formation 
[8, 16]. In fact, the tumour microenvironment plays 
a pivotal role in carcinogenesis, whereby there is 
direct interaction between the tumour and the mi-
croenvironment in which it resides. 
Axolotls: Regeneration and Cancer 
 Following limb injury in axolotls, regenera-
tion is initiated and the basal membrane keratino-
cytes migrate as a sheet to cover the wound site. 
They proliferate to form the wound epidermis and 
within days the wound becomes innervated, form-
ing the apical epithelium cap (AEC). The contact 
between the AEC and the underlying cells from 
the remaining limb help determine the orientation 
of the regenerating limb. The AEC provides pro-
regenerative signalling molecules, including FGFs, 
BMPs, TGFß, IGFs and WNTs, which are known to 
be essential for limb outgrowth during develop-
ment and adult salamander regeneration. The in-
teraction between the AEC and the underlying tis-
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sue also results in the formation of the blastema, 
which is structurally and functionally equivalent to 
a limb bud in the embryo. During the early stages 
of regeneration, the AEC supports blastema forma-
tion by promoting cellular dedifferentiation, which 
consists of cell cycle re-entry of post-mitotic dif-
ferentiated cells [17]. The blastema is likely to be 
composed of both dedifferentiated cells derived 
from muscle cells, dermal fibroblasts, as well as 
activated stem/progenitor cells. 
 Dedifferentiation occurs together with pro-
tease-induced histolysis and the release of cells 
from their tissue matrix. Proteomic studies have 
identified a number of genes that are associated 
with dedifferentiation, including msx, Nrad, rfrng 
and notch. Even though blastema cells are not re-
programmed to pluripotency, they express three of 
the four transcription factor genes used to repro-
gram adult somatic cells to pluripotency, namely, 
Klf4, Sox 2, and c-myc [18]. Changes in chromatin-
associated proteins were detected, suggesting 
transcriptional changes, chromatin modification, 
and upregulation of tumour suppressors such as 
the Kruppel-like factor 6, and Sox 6, which is re-
quired for neuronal and skeletal differentiation. 
Proteins from blastema-enriched transcripts, cirbp 
and kazald1, have been particularly implicated in 
blastema formation [19]. Other proteins implicat-
ed in extracellular matrix structure and synthesis 
(ugdh, slc23d2), regulation of EMT (fam3c, hmga2), 
and regulation of epidermal cell differentiation 
and proliferation (tgm1, ovol2, lmo7, ehf, ereg, sorbs3, 
eppk1) have also been identified [18]
 Successful regeneration will only proceed if 
none of the above-steps are impeded. Also, sig-
nalling above a threshold level from the nerve is 
necessary, for both initial blastema formation and 
growth and development of the blastema during 
the early and mid-stages of regeneration. In addi-
tion, rather than the type of nerve, it is the quantity 
of damaged nerves that is important in regenera-
tion. Also, denervation or diversion of the nerve 
at different stages of blastema formation, or mac-
rophage depletion leads to impaired communica-
tion between the epidermis and underlying cells 
and regeneration failure [20]. 
 Similar crosstalk between cancer cells and 
neuronal cells has been observed, whereby a re-
ciprocal interaction results in neuronal outgrowth 
by cancer cells and induction of cancer metasta-
sis by neuronal cells [21]. Involvement of nerves 
in tumour growth and metastasis has been de-
scribed for several tumours, including basal cell 
carcinoma [22], gastric [23] and prostate cancers 
[24]. It appears that neurotransmitters released by 
nerves and proteins such as BMP2 and FGFs have 
a direct effect on both regeneration and cancer
microenvironments. 
The potential of axolotl research in cancer treatment
 From a cancer perspective, the ability of axo-
lotls to faithfully replicate regeneration following 
injury including dedifferentiation of cells, gain of 
proliferative capabilities, and the subsequent re-
differentiation without producing abnormalities is 
of great relevance. Additionally, the limb regen-
eration models provide an important research tool 
to dissect the pathways that enable regeneration-
capable animals to evade cancer formation. 
 To aid in identifying any active molecules, 
factors or proteins that can possibly cause differ-
entiation of cancer cells, it is important to focus 
on secretary proteins including factors secreted 
within the extracellular matrix and that can have 
a direct effect on the tumour microenvironment. It 
is equally important to dissect in detail the process 
of regeneration and characterize the different fac-
tors involved in regeneration within the context of 
cancer treatment. The ability to identify the factors 
that cause re-differentiation will be helpful in can-
cer treatment. Such factors are important because 
they act on early progenitors (blastema) and result 
in differentiation into the more complex structures 
that eventually replace the lost limb. Molecular 
characterization of regeneration will help identify 
and isolate the factors involved in re-differentiation 
and avoid the adverse or deleterious effects that 
factors can have on cancer cells. Success of such 
therapeutic approaches depends on whether the 
molecules or factors can actually be taken up by 
ligands or cell surface receptors and whether they 
have a differentiation, apoptotic, and/or cytotoxic 
effect on cancer and normal cells. 
 Since some cancers are caused by a block in 
differentiation, addition of a protein extract from 
the regenerating limb of axolotls could theoreti-
cally cause the followings: activation of differentia-
tion pathways without necessarily correcting the 
underlying insult that initiated the differentiation 
block; rectification of the initial defect causing the 
differentiation blockage; and/or cause epigenetic 
modifications resulting in a more open DNA state 
which may expose transcription sites allowing ac-
cess to other differentiation, causing drugs like 
all-trans retinoic acid (ATRA). As a therapeutic 
strategy, differentiation therapy can induce tu-
mour differentiation or growth arrest by reactivat-
ing the normal control mechanisms that regulate 
cell proliferation, which is also a less toxic ap-
proach to cancer therapy when compared to the 
more cytotoxic chemotherapeutic drugs currently 
used to treat cancer patients. Results of studies 
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on cell lines and animal models that aimed at in-
ducing malignant cells to overcome their block of 
differentiation and enter the apoptotic pathways 
as an elegant alternative to killing cancer cells by 
cytotoxic therapies have been described [25]. Sub-
stances such as phorbol diesters, teleocidins, polar 
planar drugs, cytokines, retinoids, and vitamin D 
metabolites showed promising results when tested 
on different leukaemia cell lines [25]. The classic 
successful story of differentiation therapy is the 
use of ATRA for the treatment of acute promyelo-
cytic leukaemia (APL). ATRA in combination with 
arsenic trioxide has become the standard treat-
ment for APL, resulting in cure rates up to 90%
[26]. 
 With the advent of molecular biology, the focus 
is on the identification of the genes, transcription 
factors and signalling pathways orchestrating the 
cellular events that govern regeneration and can-
cer. In addition, the potential benefit that this field 
of research offers for the eventual development of 
novel medical treatments is of great importance. 
Also, new technologies such as CRISPR, RNA-seq, 
together with established molecular approaches 
such as lineage tracing, transplant assays, and in 
vitro modelling have been extremely successful in 
identifying new interacting proteins in governing 
pathways, further allowing understanding path-
way modulation and dynamics. Although much is 
known about the mechanisms of regeneration in 
the axolotl, the fine lines between controlled and 
uncontrolled cellular proliferation as seen in re-
generation and cancer are not fully understood. 
From this perspective, studying the overlapping 
stages of regeneration and focusing on the factors 
and/or molecules that cause re-differentiation be-
comes very important.
 There are huge challenges in designing drugs 
that not only target the cancer cells but can also 
modulate the microenvironment to one that does 
not favour the cancer cell phenotype. By under-
standing the processes governing cellular prolif-
eration, de-differentiation, cell cycle arrest, and 
re-differentiation using animal models like the 
axolotls, further light may be shed on the pathways 
linking regeneration and cancer with the ultimate 
aim of discovering novel therapeutic approaches 
in the treatment of cancer.
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